Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2066
https://www.valueinhealthjournal.com/article/S1098-3015(15)04142-X/fulltext
Title :
Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04142-X&doi=10.1016/j.jval.2015.09.2066
First page :
A601
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1478